HLA-B

HLA-B
已知的結構
PDB	人類UniProt搜尋: PDBe RCSB
PDBID列表
	3VCL、4U1H、4U1K、5EO1、5EO0,%%s1AGB、1AGC、1AGD、1AGE、1AGF、1M05、1MI5、3FFC、3SJV、3SKM、3SKO、3SPV、3X13、3X14、4QRP、4QRQ、4QRS、4QRT、4QRU,%%s4O2C、4O2E、4O2F,%%s3LN4、3LN5,%%s4U1J、4U1M、4U1N,%%s4U1I、4U1L、4U1S,%%s1HSA、1JGD、1JGE、1K5N、1OF2、1OGT、1UXS、1UXW、1W0V、1W0W、2A83、2BSR、2BSS、2BST、3B3I、3B6S、3BP4、3BP7、3CZF、3D18、3DTX、3HCV、3LV3、4G8G、4G8I、4G9D、4G9F、5DEF、5DEG,%%s1A1N、1A9B、1A9E、1CG9、1XH3、1ZHK、1ZHL、1ZSD、2AK4、2AXF、2AXG、2H6P、2NW3、2NX5、3BW9、3BWA、3KWW、3KXF、3LKN、3LKO、3LKP、3LKQ、3LKR、3LKS、3MV7、3MV8、3MV9、3VFS、3VFT、3VFU、3VFV、3VFW、4LNR、4PR5、4PRN、4QRR,%%s1A1M、1A1O,%%s2BVO、2BVP、2BVQ、2HJL、2RFX、2YPK、2YPL、3UPR、3VH8、3VRI、3VRJ、3WUW、3X11、3X12、5B39、5B38,%%s4JQV、4XXC,%%s1XR8、1XR9、3C9N,%%s4LCY,%%s1M6O、1N2R、1SYV、3DX6、3DX7、3DX8、3DXA、3KPL、3KPM、3KPN、3KPO、3KPP、3KPQ、3KPR、3KPS、3L3D、3L3G、3L3I、3L3J、4JQX,%%s1E27、1E28、4MJI,%%s3W39
識別號
別名	HLA-B；, AS, SPDA1, Bw-47, Bw-50, major histocompatibility complex, class I, B, B-4901, B-5001, HEL-S-83, HLA-B*45ZJ, HLA-B-3506, HLA-B-3905, HLA-B-5502, HLA-B-5602, HLA-B15, HLA-B39, HLA-B49, HLA-B50, HLA-B55, HLA-B59, HLA-B61, HLA-Cw, HLA-DRB1
外部ID	HomoloGene：134029 GeneCards：HLA-B
相關疾病
	人類免疫缺陷病毒傳染性疾病
基因位置（人類）
染色體	6號染色體
終止	31,367,067 bp
RNA表現模式
	查閱更多表現資料
基因本體
分子功能	• signaling receptor binding; • peptide antigen binding;
細胞組分	• integral component of membrane; • phagocytic vesicle membrane; • 高基氏體; • early endosome membrane; • 膜; • Golgi membrane; • 細胞膜; • integral component of plasma membrane; • cell surface; • 內質網; • MHC class I protein complex; • ER to Golgi transport vesicle membrane; • integral component of lumenal side of endoplasmic reticulum membrane; • 外排體; • secretory granule membrane; • recycling endosome membrane;
生物學過程	• antigen processing and presentation; • antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; • regulation of interleukin-12 production; • interferon-gamma-mediated signaling pathway; • immune system process; • antigen processing and presentation of peptide antigen via MHC class I; • regulation of dendritic cell differentiation; • antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; • protection from natural killer cell mediated cytotoxicity; • type I interferon signaling pathway; • 免疫反應; • regulation of immune response; • regulation of T cell anergy; • viral process; • regulation of interleukin-6 production; • neutrophil degranulation;
	Sources:Amigo / QuickGO
直系同源
	3106
	無資料
ENSG00000228964; ENSG00000234745; ENSG00000206450; ENSG00000224608; ENSG00000223532;
	ENSG00000232126
	無資料
	P01889
	無資料
	NM_005514
	無資料
	NP_005505
	無資料
	維基資料
檢視/編輯人類

HLA-B是人類白細胞抗原（HLA）的一個基因座，位於6號染色體上。

參考文獻[編輯]

^ 與HLA-B相關的疾病；在維基數據上查看/編輯參考.
^ ^2.0 ^2.1 ^2.2 GRCh38: Ensembl release 89: ENSG00000228964、ENSG00000234745、ENSG00000206450、ENSG00000224608、ENSG00000223532、ENSG00000232126 - Ensembl, May 2017
^ Human PubMed Reference:. National Center for Biotechnology Information, U.S. National Library of Medicine.

延伸閱讀[編輯]

Brown MA, Crane AM, Wordsworth BP. Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis. Curr Opin Rheumatol. 2002, 14 (4): 354–60. PMID 12118167. doi:10.1097/00002281-200207000-00004.
Carrington M, O'Brien SJ. The influence of HLA genotype on AIDS. Annu Rev Med. 2003, 54: 535–51. PMID 12525683. doi:10.1146/annurev.med.54.101601.152346.
Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT. Medical genetics: a marker for Stevens–Johnson syndrome. Nature. 2004, 428 (6982): 486. Bibcode:2004Natur.428..486C. PMID 15057820. doi:10.1038/428486a.
Colbert RA. The immunobiology of HLA-B27: variations on a theme. Curr Mol Med. 2004, 4 (1): 21–30. PMID 15011956. doi:10.2174/1566524043479293.
Colmegna I, Cuchacovich R, Espinoza LR. HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev. 2004, 17 (2): 348–69. PMC 387405 . PMID 15084505. doi:10.1128/CMR.17.2.348-369.2004. Full text
Cooke GS, Hill AV. Genetics of susceptibility to human infectious disease. Nat Rev Genet. 2001, 2 (12): 967–77. PMID 11733749. doi:10.1038/35103577.
Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, O'Brien SJ, Carrington M. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med. 2001, 344 (22): 1668–75. PMID 11386265. doi:10.1056/NEJM200105313442203.
Hetherington S, Hughes AR, Mosteller M, Shortino D, Baker KL, Spreen W, Lai E, Davies K, Handley A, Dow DJ, Fling ME, Stocum M, Bowman C, Thurmond LM, Roses AD. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet. 2002, 359 (9312): 1121–2. PMID 11943262. doi:10.1016/S0140-6736(02)08158-8.
Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS, Chen MJ, Lai PC, Wu MS, Chu CY, Wang KH, Chen CH, Fann CS, Wu JY, Chen YT. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA. 2005, 102 (11): 4134–9. Bibcode:2005PNAS..102.4134H. PMC 554812 . PMID 15743917. doi:10.1073/pnas.0409500102. Full text
Khan MA, Ball EJ. Genetic aspects of ankylosing spondylitis. Best Pract Res Clin Rheumatol. 2002, 16 (4): 675–90. PMID 12406434.
Khan MA. Update on spondyloarthropathies. Ann Intern Med. 2002, 136 (12): 896–907. PMID 12069564. Full text (PDF)（頁面存檔備份，存於網際網路檔案館）
Letvin NL, Walker BD. Immunopathogenesis and immunotherapy in AIDS virus infections. Nat Med. 2003, 9 (7): 861–6. PMID 12835706. doi:10.1038/nm0703-861.
Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, Hallahan CW, Selig SM, Schwartz D, Sullivan J, Connors M. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA. 2000, 97 (6): 2709–14. Bibcode:2000PNAS...97.2709M. PMC 15994 . PMID 10694578. doi:10.1073/pnas.050567397. Full text（頁面存檔備份，存於網際網路檔案館）
Sheehan NJ. The ramifications of HLA-B27. J R Soc Med. 2004, 97 (1): 10–4. PMC 1079257 . PMID 14702356. doi:10.1258/jrsm.97.1.10.
Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U, Chucherd P, Konyoung P, Vannaprasaht S, Choonhakarn C, Pisuttimarn P, Sangviroon A, Tassaneeyakul W. Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population. Pharmacogenet Genomics. 2009, 19 (9): 704–9. PMID 19696695. doi:10.1097/FPC.0b013e328330a3b8.
Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH, Konyoung P, Khunarkornsiri U, Auvichayapat N, Pavakul K, Kulkantrakorn K, Choonhakarn C, Phonhiamhan S, Piyatrakul N, Aungaree T, Pongpakdee S, Yodnopaglaw P. Association between HLA-B*1502 and carbamazepine–induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia. 2010, 51 (5): 926–30. PMID 20345939. doi:10.1111/j.1528-1167.2010.02533.x. Full text(PDF)（頁面存檔備份，存於網際網路檔案館）

This article incorporates public domain text from The U.S. National Library of Medicine（頁面存檔備份，存於網際網路檔案館）

外部連結[編輯]

[1] 與HLA-B相關的疾病；在維基數據上查看/編輯參考.

[refGRCh38Ensembl-2] 2.0 ^2.1 ^2.2 GRCh38: Ensembl release 89: ENSG00000228964、ENSG00000234745、ENSG00000206450、ENSG00000224608、ENSG00000223532、ENSG00000232126 - Ensembl, May 2017

[3] Human PubMed Reference:. National Center for Biotechnology Information, U.S. National Library of Medicine.

[1]

[2]

[3]